Mood stabilization
5 drugs
Marketing claims without evidence base
The drug is promoted for these uses outside international guidelines. Each entry below is analyzed against AEMPS, FDA, EMA, Cochrane and major RCTs.
- DGamma-aminobutyric acid (GABA)Not recommended · Inhibitory CNS neurotransmitter; as a supplement – amino acid for oral useGamma-aminobutyric acid (GABA) is an inhibitory neurotransmitter; as a supplement it's marketed for calmness and mood stability. Clear benefit for this use hasn't been shown: the molecule barely crosses the blood-brain barrier, and there's no solid evidence for an effect on mood. For mood swings and anxiety, psychotherapy and clinician-prescribed medications with proven efficacy actually help. GABA is harmless in this role, but don't take it instead of treatment with proven benefit – you could miss the care you need.
- DVitamin B12 (cobalamin)Not recommended · Water-soluble B-vitamin; cofactor of methionine synthase and methylmalonyl-CoA mutaseVitamin B12 (cobalamin) is a water-soluble vitamin the body needs for the nervous system and blood formation. It is sometimes promoted as a supplement for mood stabilization and emotional swings. There is no convincing evidence that B12 helps with this: in people with normal vitamin levels, taking extra B12 does not even out mood. The vitamin itself is harmless at usual doses, but ongoing mood swings respond to psychotherapy and treatment chosen by a doctor. Do not use B12 in place of therapy with proven benefit, or you may miss the care you actually need.
- FCarbamazepineNot recommended · Antiepileptics. Carboxamide derivativesCarbamazepine is an antiepileptic drug. It is prescribed for epilepsy, trigeminal neuralgia, and bipolar disorder (AAN 2018 and NICE NG137 guidelines). For everyday mood stabilization, carbamazepine does not work: no clinical studies of such use exist. The drug carries serious risks: severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis) in HLA-B*1502 carriers, aplastic anemia, agranulocytosis (FDA boxed warning). Carbamazepine also strongly accelerates metabolism of many other drugs (CYP3A4 inducer), sharply reducing their effectiveness. If carbamazepine was prescribed for mood stabilization, consider seeking a second opinion.
- FEslicarbazepine acetateNot recommended · Antiepileptic, carboxamide derivativeEslicarbazepine acetate is an antiepileptic drug. It is prescribed only for focal epilepsy, as monotherapy or as add-on to other antiepileptics (AAN 2018, AEMPS Ficha Técnica). For mood stabilization or anxiety, no efficacy has been demonstrated: no clinical studies of such use exist. The drug has serious side effects: hyponatremia (a dangerous drop in blood sodium), skin reactions, dizziness, somnolence. If eslicarbazepine was prescribed for mood stabilization or anxiety, consider seeking a second opinion.
- FLamotrigineNot recommended · Antiepileptic with dual mechanismLamotrigine is an antiepileptic drug. It is prescribed for epilepsy and for maintenance treatment of bipolar I disorder (AAN 2018 and NICE NG185 guidelines). For everyday mood stabilization, lamotrigine does not work: no clinical studies of such use exist. The main risk is severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis), especially with rapid dose escalation or combination with valproate (FDA boxed warning). If lamotrigine was prescribed for mood stabilization, consider seeking a second opinion.
How to read tiers A–F
Evidence tiers belong to the drug-indication pair, not to the drug as a whole: the same substance can be A for one condition and F for another.
- AStrong evidence – first or second line in international guidelines
- BRecommended in selected cases
- CStudy data contradict each other
- DBenefit not proven, no documented harm
- FDocumented harm, or risk without benefit